Hoping to make early heart disease screening more accessible and accurate, Cardisio has closed a $4.0M seed round.
The company developed Cardisiography, an AI-based 3D-vectorcardiography designed to detect pathological signs of arterial and structural heart diseases with over 90% sensitivity. This innovative technology aims to sharply reduce unnecessary deaths, impaired quality of life, and medical expenses, offering a more exact alternative to conventional diagnostics.


















